CASPIAN Sets record straight after misleading claims by HomeAgain andVeriChip implant manufacturers.A new paper titled "Microchip-Induced Tumors in Laboratory Rodents andDogs: A Review of the Literature 19902006" has been released today byCASPIAN. The full, 48-page paper provides a definitive review of theacademic literature showing a causal link between implanted radio-frequency(RFID) microchip transponders and cancer in laboratory rodents and dogs. Inaddition, a brief, four-page synopsis of the full report is being madeavailable.Eleven articles previously published in toxicology and pathology journalsare evaluated in the report. In six of the articles, between 0.8% and 10.2%of laboratory mice and rats developed malignant tumors around or adjacent tothe microchips, and several researchers suggested the actual tumor rate mayhave been higher. Two additional articles reported microchip-related cancerin dogs.In almost all cases, the malignant tumors, typically sarcomas, arose at thesite of the implants and grew to surround and fully encase the devices. Inseveral cases the tumors also metastasized or spread to other parts of theanimals.Public revelation of a casual link between microchipping and cancer inanimals has prompted widespread public concern over the safety ofimplantable microchips. The story was first broken to the public inSeptember through an article written by Associated Press Reporter ToddLewan. Prior to the AP story, the journal articles were completely unknownoutside of small academic circles."The AP did a superb job informing the public of the existence of thesejournal articles," said Dr. Katherine Albrecht, a leading privacy expert andlong-time VeriChip opponent who authored the new paper."Unfortunately," Dr. Albrecht added, "a lot of misinformation about thecancer research has circulated since Mr. Lewan's article was published.I wrote the report to set the record straight."The animal-microchip study findings were so compelling that one of Mr.Lewan's sources, Dr. Robert Benezra, head of the Cancer Biology GeneticsProgram at the Memorial Sloan-Kettering Cancer Center in New York, wasquoted as saying, "There's no way in the world, having read thisinformation, that I would have one of those chips implanted in my skin, orin one of my family members."Nevertheless, representatives of the chipping industry have made inaccuratepublic statements about the research findings in an effort to confuse thepublic.Scott Silverman, CEO of the VeriChip Corporation which makes thecontroversial VeriChip human implant, recently provided inaccurateinformation to Time Magazine. Mr. Silverman is quoted as saying that none ofthe tumors found in mice in a 2006 French study were malignant.In fact, not only were the tumors malignant sarcomas, but most of theafflicted animals died prematurely as a result of the microchip-associatedtumor s.In addition, Destron Fearing, makers of the HomeAgain pet implant, dismisseda finding of fibrosarcoma--a highly lethal cancer--as 'benign'in a recent report.A fibrosarcoma is a type of sarcoma, a malignant tumor of soft tissue thatconnects, supports or surrounds other structures and organs of the body. Dr.Timothy Jennings, an expert on implant-induced cancers in humans, said hewas "not aware of any nosology incorporating an entity of 'benignfibrosarcoma'" and agreed that "any tumor classified as sarcoma should beviewed as malignant.""Either VeriChip and the makers of HomeAgain actually don't understand thedifference between a benign fibroma and a malignant fibrosarcoma,"noted Dr. Albrecht, "or they're deliberately lying to the public. Eitherway, it's clear they can't be trusted. We hope our new report will set therecord straight."The report includes a one- to three-page writeup on each of the originalstudies. In addition to a detailed review of the academic literature, thereport contains recommendations for patients, pet owners, veterinarians, andpolicy makers, including the following: (1) Further microchipping of humansshould be immediately discontinued; (2) Implanted patients should beinformed in writing of the research findings and offered a procedure formicrochip removal; and (3) Policy makers should reverse all animalmicrochipping mandates.As part of its public awareness campaign, CASPIAN will be issuing copies ofthe new report to leading policy and decision makers.The full 48-page report and four-page synopsis are also immediatelyavailable for public download at http://www.antichips.com/cancer/
I live in an apartment so i have a strictly indoors cat
I need to find the article, but it has now been shown that microchip implants can cause sarcomas (cancer) in pets.
CASPIAN Sets record straight after misleading claims by HomeAgain andVeriChip implant manufacturers.A new paper titled "Microchip-Induced Tumors in Laboratory Rodents andDogs: A Review of the Literature 19902006" has been released today byCASPIAN. The full, 48-page paper provides a definitive review of theacademic literature showing a causal link between implanted radio-frequency(RFID) microchip transponders and cancer in laboratory rodents and dogs. Inaddition, a brief, four-page synopsis of the full report is being madeavailable.Eleven articles previously published in toxicology and pathology journalsare evaluated in the report. In six of the articles, between 0.8% and 10.2%of laboratory mice and rats developed malignant tumors around or adjacent tothe microchips, and several researchers suggested the actual tumor rate mayhave been higher. Two additional articles reported microchip-related cancerin dogs.In almost all cases, the malignant tumors, typically sarcomas, arose at thesite of the implants and grew to surround and fully encase the devices. Inseveral cases the tumors also metastasized or spread to other parts of theanimals.Public revelation of a casual link between microchipping and cancer inanimals has prompted widespread public concern over the safety ofimplantable microchips. The story was first broken to the public inSeptember through an article written by Associated Press Reporter ToddLewan. Prior to the AP story, the journal articles were completely unknownoutside of small academic circles."The AP did a superb job informing the public of the existence of thesejournal articles," said Dr. Katherine Albrecht, a leading privacy expert andlong-time VeriChip opponent who authored the new paper."Unfortunately," Dr. Albrecht added, "a lot of misinformation about thecancer research has circulated since Mr. Lewan's article was published.I wrote the report to set the record straight."The animal-microchip study findings were so compelling that one of Mr.Lewan's sources, Dr. Robert Benezra, head of the Cancer Biology GeneticsProgram at the Memorial Sloan-Kettering Cancer Center in New York, wasquoted as saying, "There's no way in the world, having read thisinformation, that I would have one of those chips implanted in my skin, orin one of my family members."Nevertheless, representatives of the chipping industry have made inaccuratepublic statements about the research findings in an effort to confuse thepublic.Scott Silverman, CEO of the VeriChip Corporation which makes thecontroversial VeriChip human implant, recently provided inaccurateinformation to Time Magazine. Mr. Silverman is quoted as saying that none ofthe tumors found in mice in a 2006 French study were malignant.In fact, not only were the tumors malignant sarcomas, but most of theafflicted animals died prematurely as a result of the microchip-associatedtumor s.In addition, Destron Fearing, makers of the HomeAgain pet implant, dismisseda finding of fibrosarcoma--a highly lethal cancer--as 'benign'in a recent report.A fibrosarcoma is a type of sarcoma, a malignant tumor of soft tissue thatconnects, supports or surrounds other structures and organs of the body. Dr.Timothy Jennings, an expert on implant-induced cancers in humans, said hewas "not aware of any nosology incorporating an entity of 'benignfibrosarcoma'" and agreed that "any tumor classified as sarcoma should beviewed as malignant.""Either VeriChip and the makers of HomeAgain actually don't understand thedifference between a benign fibroma and a malignant fibrosarcoma,"noted Dr. Albrecht, "or they're deliberately lying to the public. Eitherway, it's clear they can't be trusted. We hope our new report will set therecord straight."The report includes a one- to three-page writeup on each of the originalstudies. In addition to a detailed review of the academic literature, thereport contains recommendations for patients, pet owners, veterinarians, andpolicy makers, including the following: (1) Further microchipping of humansshould be immediately discontinued; (2) Implanted patients should beinformed in writing of the research findings and offered a procedure formicrochip removal; and (3) Policy makers should reverse all animalmicrochipping mandates.As part of its public awareness campaign, CASPIAN will be issuing copies ofthe new report to leading policy and decision makers.The full 48-page report and four-page synopsis are also immediatelyavailable for public download at http://www.antichips.com/cancer/